Actinium Pharmaceuticals Financial Overview
Actinium Pharmaceuticals's market cap is currently $52.72M. The company's EPS TTM is $-0.16; its P/E ratio is -1.52; Actinium Pharmaceuticals is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
